{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:27:35Z","timestamp":1780388855251,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,10]]},"DOI":"10.7759\/cureus.98904","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T17:02:00Z","timestamp":1765386120000},"source":"Crossref","is-referenced-by-count":1,"title":["Management Challenges of Life-Threatening Thrombosis and Hemorrhage in a Jehovah\u2019s Witness Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Naeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sughra M","family":"Mangrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaiza","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usmaan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203720","article-title":"The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study","volume":"69","author":"Donaldson JW","year":"2014","unstructured":"Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study. Thorax. 2014, 69:161-7. 10.1136\/thoraxjnl-2013-203720","journal-title":"Thorax"},{"key":"ref2","article-title":"Hereditary hemorrhagic telangiectasia","author":"McDonald J","year":"2021","unstructured":"McDonald J, Stevenson DA. Hereditary hemorrhagic telangiectasia. GeneReviews. Adam P, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (ed): University of Washington, Seattle, WA; 2021."},{"key":"ref3","unstructured":"Hereditary haemorrhagic telangiectasia. (2006). Accessed. December 10, 2025: https:\/\/dermnetnz.org\/topics\/hereditary-haemorrhagic-telangiectasia."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0775-8","article-title":"Cura\u00e7ao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2)","volume":"22","author":"McDonald J","year":"2020","unstructured":"McDonald J, Bayrak-Toydemir P, DeMille D, Wooderchak-Donahue W, Whitehead K. Cura\u00e7ao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2). Genet Med. 2020, 22:1201-5. 10.1038\/s41436-020-0775-8","journal-title":"Genet Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.11.013","article-title":"Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding","volume":"93","author":"Iyer VN","year":"2018","unstructured":"Iyer VN, Apala DR, Pannu BS, et al.. Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding. Mayo Clin Proc. 2018, 93:155-66. 10.1016\/j.mayocp.2017.11.013","journal-title":"Mayo Clin Proc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001538","article-title":"Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study","volume":"84","author":"Donaldson JW","year":"2015","unstructured":"Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study. Neurology. 2015, 84:1886-93. 10.1212\/WNL.0000000000001538","journal-title":"Neurology"},{"key":"ref7","unstructured":"National early warning score (NEWS). (2025). Accessed. December 10, 2025: https:\/\/www.mdcalc.com\/calc\/1873\/national-early-warning-score-news."},{"key":"ref8","unstructured":"CHA\u2082DS\u2082-VASc score for atrial fibrillation stroke risk. (2025). Accessed. December 10, 2025: https:\/\/www.mdcalc.com\/calc\/801\/cha2ds2-vasc-score-atrial-fibrillation-stroke-risk."},{"key":"ref9","article-title":"Glasgow coma scale","author":"Jain S","year":"2025","unstructured":"Jain S, Margetis K, Iverson LM. Glasgow coma scale. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref10","unstructured":"The Gold Standards Framework. proactive identification guidance (PIG). (2022). Accessed: December 10, 2025: https:\/\/www.goldstandardsframework.org.uk\/wp-content\/uploads\/2025\/07\/Proactive-Identification-Guidance.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.8.585","article-title":"Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations","volume":"40","author":"Berg J","year":"2003","unstructured":"Berg J, Porteous M, Reinhardt D, et al.. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet. 2003, 40:585-90. 10.1136\/jmg.40.8.585","journal-title":"J Med Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.060061","article-title":"Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation","volume":"126","author":"Lane DA","year":"2012","unstructured":"Lane DA, Lip GY. Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation. 2012, 126:860-5. 10.1161\/CIRCULATIONAHA.111.060061","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen JB","year":"2011","unstructured":"Olesen JB, Lip GY, Hansen ML, et al.. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011, 342:d124. 10.1136\/bmj.d124","journal-title":"BMJ"},{"key":"ref14","article-title":"Management of atrial fibrillation in patients with heart failure","volume":"7","author":"Darby AE","year":"2014","unstructured":"Darby AE. Management of atrial fibrillation in patients with heart failure. J Atr Fibrillation. 2014, 7:1105.","journal-title":"J Atr Fibrillation"},{"key":"ref15","article-title":"[Atrial fibrillation in patients with heart failure: treatment and management]","volume":"71","author":"Shiga T","year":"2013","unstructured":"Shiga T. [Atrial fibrillation in patients with heart failure: treatment and management]. Nihon Rinsho. 2013, 71:131-5.","journal-title":"Nihon Rinsho"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1598005","article-title":"Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review","volume":"43","author":"Bikdeli B","year":"2017","unstructured":"Bikdeli B, Abou Ziki MD, Lip GY. Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review. Semin Thromb Hemost. 2017, 43:849-63. 10.1055\/s-0036-1598005","journal-title":"Semin Thromb Hemost"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9036","article-title":"Once-daily vs. twice-daily dosing of enoxaparin for the management of venous thromboembolism: a systematic review and meta-analysis","volume":"20","author":"Niu J","year":"2020","unstructured":"Niu J, Song Y, Li C, Ren H, Zhang W. Once-daily vs. twice-daily dosing of enoxaparin for the management of venous thromboembolism: a systematic review and meta-analysis. Exp Ther Med. 2020, 20:3084-95. 10.3892\/etm.2020.9036","journal-title":"Exp Ther Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1179-1","article-title":"Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Shovlin CL","year":"2019","unstructured":"Shovlin CL, Millar CM, Droege F, et al.. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2019, 14:210. 10.1186\/s13023-019-1179-1","journal-title":"Orphanet J Rare Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01579-2","article-title":"Predictors of mortality in patients with hereditary hemorrhagic telangiectasia","volume":"16","author":"Thompson KP","year":"2021","unstructured":"Thompson KP, Nelson J, Kim H, et al.. Predictors of mortality in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2021, 16:12. 10.1186\/s13023-020-01579-2","journal-title":"Orphanet J Rare Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-3013","article-title":"Patient blood management when blood is not an option: a report of two cases","volume":"11","author":"Jung J","year":"2022","unstructured":"Jung J, Lee M, Kang Y, Cho SH. Patient blood management when blood is not an option: a report of two cases. Ann Palliat Med. 2022, 11:2768-72. 10.21037\/apm-21-3013","journal-title":"Ann Palliat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440544-management-challenges-of-life-threatening-thrombosis-and-hemorrhage-in-a-jehovahs-witness-patient-with-hereditary-hemorrhagic-telangiectasia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T17:02:01Z","timestamp":1765386121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440544-management-challenges-of-life-threatening-thrombosis-and-hemorrhage-in-a-jehovahs-witness-patient-with-hereditary-hemorrhagic-telangiectasia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.98904","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}